Investment Summit 2025: What Do Investors Need to See From Emerging Biotech? | ATW 2025
💰 What makes a biotech investable? This panel of seasoned investors shares their behind-the-scenes approach to evaluating startups and emerging CGT companies.
💡 Key Takeaways:
🔹 Sven Kili on scientific & regulatory due diligence
🔹 John Watkins on financial stability & market potential
🔹 Lynn Fischer on positioning biotech for funding success
🔹 Tay Salimullah on emerging trends & the next wave of biotech investment
Speakers:
🔹 Sven Kili – Partner, Saisei Ventures
🔹 John Watkins – Director, Teacher Retirement System of Texas
🔹 Lynn Fischer – CEO, KMAK Capital
🔹 Tay Salimullah – Venture Partner, 4BIO CAPITAL
🎟️ Get investor-ready—join us at ATW 2026!
🔹 Pre-register now → https://ow.ly/5Ssp50Vaotw
📖 Download the ATW 2025 Show Brochure → https://ow.ly/raF450Vaouz
#ATW26 #BiotechInvestment #VentureCapital #CGT #AdvancedTherapies #InvestorInsight